This webinar addresses gene patenting and its implications for women around the world. Participants learn about the latest news in the Myriad Genetics case, along with the basic science, patent law, and current campaign efforts. Breast Cancer Action is a plaintiff in the lawsuit to invalidate Myriad Genetics’ patents on the breast cancer genes BRCA 1 and 2 because patients should always come before profits.
- About BCAction
- Our Take on Breast Cancer
- Educational Resources
- Think Before You Pink® 2020: We Can’t Be Pink’d!
- The Source